Premium Nahrungsergänzungsmittel | artgerecht

Sevoflurane – Inhaled Anesthetic Explained

Sevoflurane is an inhaled anesthetic used for the induction and maintenance of general anesthesia. It acts rapidly and is well tolerated by patients of all ages.

Regular tips about health Regular tips about health

Things worth knowing about "Sevoflurane"

Sevoflurane is an inhaled anesthetic used for the induction and maintenance of general anesthesia. It acts rapidly and is well tolerated by patients of all ages.

What is Sevoflurane?

Sevoflurane is a volatile inhaled anesthetic widely used in modern anesthesia practice. It belongs to the class of halogenated ethers and is delivered via a calibrated vaporizer into a breathing gas mixture, which the patient inhales through a face mask or endotracheal tube. Sevoflurane is approved for both the induction and maintenance of general anesthesia in adults and children and is one of the most commonly used inhalation agents worldwide.

Mechanism of Action

Sevoflurane exerts its anesthetic effects primarily by modulating ion channels in the central nervous system. It enhances the inhibitory neurotransmitter GABA (gamma-aminobutyric acid) at GABA_A receptors and inhibits excitatory receptors such as NMDA receptors. This results in:

Loss of consciousness (hypnosis)
Pain relief (analgesia)
Muscle relaxation
Suppression of reflexes to surgical stimuli

A key measure of potency for inhaled anesthetics is the MAC value (Minimum Alveolar Concentration). The MAC of sevoflurane in adults is approximately 2.0 vol-%, meaning that at this concentration, 50% of patients will not move in response to a surgical incision.

Application and Dosage

Sevoflurane is administered exclusively in clinical settings by qualified anesthesia professionals. Dosing is individualized based on several factors:

Patient age and body weight
Type and duration of the surgical procedure
Concomitant medications (e.g., opioids, neuromuscular blocking agents)
Pre-existing conditions (e.g., hepatic or renal impairment)

Typical induction concentrations range from 4 to 8 vol-%, while maintenance concentrations are usually between 0.5 and 3 vol-%. Sevoflurane has a low blood-gas partition coefficient of 0.65, which allows for rapid onset and offset of anesthesia and precise depth control.

Advantages Over Other Inhaled Anesthetics

Sevoflurane has several properties that make it the preferred inhaled anesthetic in many clinical settings:

Pleasant odor: Unlike desflurane, sevoflurane has a mild, sweet smell, making it ideal for mask induction, particularly in pediatric patients.
Rapid kinetics: Its low blood solubility enables fast induction and quick recovery.
Cardiovascular stability: Sevoflurane has less impact on heart rhythm compared to older halogenated agents.
Pediatric suitability: Its non-pungent odor makes it the agent of choice for inhalation induction in children.

Side Effects

Like all anesthetic agents, sevoflurane can cause side effects. The most common include:

Low blood pressure (hypotension)
Postoperative nausea and vomiting (PONV)
Respiratory depression
Bradycardia (slow heart rate)
Headache and dizziness upon waking
Rarely: Malignant hyperthermia – a life-threatening skeletal muscle disorder in genetically predisposed individuals

Another consideration is the formation of the degradation product Compound A, which can occur at low fresh gas flows when sevoflurane interacts with certain CO₂ absorbents. While nephrotoxic in animal studies, clinically relevant kidney damage in humans has not been demonstrated at recommended flow rates. Nevertheless, fresh gas flows below 1 L/min are generally avoided during prolonged procedures as a precaution.

Contraindications

Sevoflurane should not be used in patients with:

Known hypersensitivity to sevoflurane or other halogenated anesthetics
Known or suspected genetic predisposition to malignant hyperthermia
A history of liver injury attributed to halogenated anesthetic agents (e.g., halothane-induced hepatitis)

Environmental Considerations

Sevoflurane is a greenhouse gas with a measurable global warming potential (GWP). While its climate impact is significantly lower than that of desflurane, anesthesiologists worldwide are increasingly adopting low-flow anesthesia techniques to reduce fresh gas consumption and minimize environmental impact.

References

Eger EI 2nd et al. – Sevoflurane: A compendium and reference. Anesthesia & Analgesia, 1995; 81(6 Suppl): S1–S3.
Patel SS, Goa KL – Sevoflurane: A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia. Drugs, 1996; 51(4): 658–700.
European Medicines Agency (EMA) – Summary of Product Characteristics: Sevoflurane. Available at: www.ema.europa.eu

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.